Squarepoint’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Squarepoint’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-34,707	Closed	-$1.25M	–	4014
2022 Q4	$1.25M	Buy	+34,707	New	+$868K	﹤0.01%	1671
2022 Q1	–	Sell	-11,305	Closed	-$268K	–	3794
2021 Q4	$268K	Buy	+11,305	New	+$262K	﹤0.01%	2515

Squarepoint's IMGO Position: Q1 2023 in Review

Squarepoint sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 34,707 shares — an estimated $1.25M sold.

Squarepoint first reported a position in IMGO in Q4 2021 and held it in 2 quarters. The position peaked at $1.25M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Squarepoint reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Squarepoint sold 34,707 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $1.25M.
Squarepoint first reported a position in Imago BioSciences, Inc. Common stock in Q4 2021 and held it in 2 quarters.
Squarepoint's Imago BioSciences, Inc. Common stock position peaked at $1.25M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.